Catheter Precision Inc. (VTAK) - Net Assets
Based on the latest financial reports, Catheter Precision Inc. (VTAK) has net assets worth $6.65 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($15.86 Million) and total liabilities ($9.21 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Catheter Precision Inc. liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $6.65 Million |
| % of Total Assets | 41.94% |
| Annual Growth Rate | N/A |
| 5-Year Change | -51.36% |
| 10-Year Change | N/A |
| Growth Volatility | 59.49 |
Catheter Precision Inc. - Net Assets Trend (2016–2025)
This chart illustrates how Catheter Precision Inc.'s net assets have evolved over time, based on quarterly financial data. Also explore Catheter Precision Inc. balance sheet assets for the complete picture of this company's asset base.
Annual Net Assets for Catheter Precision Inc. (2016–2025)
The table below shows the annual net assets of Catheter Precision Inc. from 2016 to 2025. For live valuation and market cap data, see market cap of Catheter Precision Inc..
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $6.65 Million | -43.43% |
| 2024-12-31 | $11.76 Million | -44.52% |
| 2023-12-31 | $21.19 Million | +128.87% |
| 2022-12-31 | $9.26 Million | -32.28% |
| 2021-12-31 | $13.67 Million | -35.34% |
| 2020-12-31 | $21.15 Million | -36.21% |
| 2019-12-31 | $33.15 Million | -50.30% |
| 2018-12-31 | $66.70 Million | +975.97% |
| 2017-12-31 | $-7.62 Million | -1903.95% |
| 2016-12-31 | $-380.00K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Catheter Precision Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 29791100000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $316.59 Million | 4488.08% |
| Total Equity | $7.05 Million | 100.00% |
Catheter Precision Inc. Competitors by Market Cap
The table below lists competitors of Catheter Precision Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Tristel
LSE:TSTL
|
$2.25 Million |
|
Gibui Holdings Ltd
TA:GIBUI
|
$2.25 Million |
|
The Income & Growth VCT
LSE:IGV
|
$2.25 Million |
|
Augmentum Fintech PLC
LSE:AUGM
|
$2.25 Million |
|
Crown LNG Holdings Limited Warrants
NASDAQ:CGBSW
|
$2.23 Million |
|
Supreme PLC
LSE:SUP
|
$2.23 Million |
|
Ceylon Graphite Corp
V:CYL
|
$2.23 Million |
|
Crest Nicholson Holdings plc
LSE:CRST
|
$2.23 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Catheter Precision Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 11,757,000 to 7,054,000, a change of -4,703,000 (-40.0%).
- Net loss of 17,183,000 reduced equity.
- New share issuances of 4,921,000 increased equity.
- Other factors increased equity by 7,559,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-17.18 Million | -243.59% |
| Share Issuances | $4.92 Million | +69.76% |
| Other Changes | $7.56 Million | +107.16% |
| Total Change | $- | -40.00% |
Book Value vs Market Value Analysis
This analysis compares Catheter Precision Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 130.21x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | $-39.24 | $0.85 | x |
| 2017-12-31 | $-786.43 | $0.85 | x |
| 2018-12-31 | $9033.72 | $0.85 | x |
| 2019-12-31 | $3152.34 | $0.85 | x |
| 2020-12-31 | $622.34 | $0.85 | x |
| 2021-12-31 | $135.38 | $0.85 | x |
| 2022-12-31 | $8.96 | $0.85 | x |
| 2023-12-31 | $3.86 | $0.85 | x |
| 2024-12-31 | $3.60 | $0.85 | x |
| 2025-12-31 | $0.01 | $0.85 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Catheter Precision Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -243.59%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2098.05%
- • Asset Turnover: 0.05x
- • Equity Multiplier: 2.25x
- Recent ROE (-243.59%) is below the historical average (-158.01%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 0.00% | -70.31% | 1.02x | 0.00x | $-4.16 Million |
| 2017 | 0.00% | -302.64% | 0.52x | 0.00x | $-17.00 Million |
| 2018 | -46.22% | -492.76% | 0.08x | 1.11x | $-37.50 Million |
| 2019 | -171.82% | -791.18% | 0.16x | 1.33x | $-60.27 Million |
| 2020 | -170.45% | -818.27% | 0.13x | 1.58x | $-38.16 Million |
| 2021 | -183.35% | -113954.55% | 0.00x | 1.54x | $-26.44 Million |
| 2022 | -290.12% | -191892.86% | 0.00x | 1.82x | $-27.79 Million |
| 2023 | -333.00% | -15966.52% | 0.01x | 1.45x | $-72.69 Million |
| 2024 | -141.56% | -3962.62% | 0.02x | 2.36x | $-17.82 Million |
| 2025 | -243.59% | -2098.05% | 0.05x | 2.25x | $-17.89 Million |
Industry Comparison
This section compares Catheter Precision Inc.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,920,959,967
- Average return on equity (ROE) among peers: -107.97%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Catheter Precision Inc. (VTAK) | $6.65 Million | 0.00% | 1.38x | $2.24 Million |
| Abbott Laboratories (ABT) | $17.48 Billion | 27.92% | 1.43x | $151.99 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $18.68 Million |
| Aethlon Medical Inc (AEMD) | $-704.50K | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $105.73 Million | -116.68% | 0.61x | $903.35K |
| Adapthealth Corp (AHCO) | $1.58 Billion | 5.73% | 1.84x | $1.39 Billion |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $784.36K | -284.06% | 0.72x | $10.14 Million |
| Allurion Technologies, Inc. (ALUR) | $-32.31 Million | 0.00% | 0.00x | $10.18 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $1.96 Million | -680.21% | 0.05x | $3.99 Million |
| Artivion Inc (AORT) | $148.69 Million | 4.92% | 0.18x | $1.09 Billion |
| Apyx Medical Inc (APYX) | $412.30K | -37.38% | 7.73x | $153.68 Million |
About Catheter Precision Inc.
Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States and Europe. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally … Read more